{"version":"1.0","type":"link","title":"Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab.","author_name":"Güren AK 외","author_url":"https://prs-insight.online/author/G%C3%BCren%20AK","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/75994","thumbnail_width":1200,"thumbnail_height":630}